The second day of this year’s Global Class Actions Symposium compared the US with the EU, as well as examining mass torts and product liability claims. No discussion centred on the US can ignore the ...
This week’s review of global disputes market developments takes in the UK, US, Middle East, Europe and Australia. Set up your free account and receive complimentary access to CDR's extensive coverage ...
A prominent IP lawyer who acted for SkyKick in its high-profile legal battle against Sky has left Fieldfisher to join rival Osborne Clarke in the UK capital. Osborne Clarke is fortifying its ...
The former joint head of Orrick’s Geneva office will head Pinsent Masons’ construction disputes group in Riyadh. Scott focuses her work on international arbitration and dispute resolution, with an ...
The firm has snapped up a partner in Santiago to grow its Latin American disputes offering. Larraín focuses on civil litigation and arbitration, with experience advising on commercial and judicial ...
Day one of the Global Class Actions Symposium 2024 served up an afternoon of panel discussions on the challenges of certification, the crucial role of economists, and a surprising tale about ...
CDR (Commercial Dispute Resolution) is an online magazine for litigation and arbitration professionals worldwide. Published by Global Legal Group, CDR provides critical business intelligence with ...
The single-office Singapore firm has added aviation, logistics and arbitration expertise from Clifford Chance’s outpost in the city-state. Oon & Bazul has recruited Elan Krishna as a partner in its ...
An Australian-based exploration company has secured USD 4.4 million to fund an ICSID arbitration against the West African country. Australian-headquartered gold developer Sarama Resources is set to ...
The case outcome denies a vast category of UK investors the ability to seek redress if misled by a company in which they invested. A securities case against banking giant Barclays has concluded with ...
The European Commission has held that the pharmaceutical company breached competition law by misuse of the patent system alongside a targeted disparagement campaign against competing products. Teva ...